Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC)

PURPOSE: This phase II study evaluated the efficacy and safety of anastrozole concurrent with tegafur/uracil (UFT) as neoadjuvant therapy for ER-positive postmenopausal breast cancer. METHODS: Postmenopausal Japanese women with ER-positive, HER2-negative, T2,N0-1,M0 breast cancer seen at tertiary ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Takahiro, Sagara, Yasuaki, Takashima, Tsutomu, Matsunami, Nobuki, Masuda, Norikazu, Miyoshi, Yasuo, Taguchi, Tetsuya, Aono, Toyokazu, Ito, Toshikazu, Kagimura, Tatsuo, Noguchi, Shinzaburo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854715/
https://www.ncbi.nlm.nih.gov/pubmed/29468454
http://dx.doi.org/10.1007/s00280-018-3544-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854715/
https://www.ncbi.nlm.nih.gov/pubmed/29468454
http://dx.doi.org/10.1007/s00280-018-3544-5

Ejemplares similares